Biotech Values

[DewDiligence]

Would be interesting if generic Copaxone gets approved before generic Lovenox.

Absent a summary judgment by the Court on the patent case, the FDA cannot grant final approval of NVS/MNTA’s Copaxone ANDA until Feb 2011, when the 30-month Hatch-Waxman stay expires.